Levilimab (BCD-089) is a fully humanized monoclonal antibody that targets the interleukin-6 receptor (IL-6R), playing a crucial role in the modulation of inflammatory responses. This antibody is specifically designed for the study of inflammatory diseases, including rheumatoid arthritis, where IL-6R-mediated signaling is implicated in disease pathology and progression. Levilimab provides a valuable tool for researchers investigating the therapeutic potential of IL-6R inhibition in inflammation and autoimmune disorders.
Levilimab (BCD-089) is a fully humanized monoclonal antibody that targets the interleukin-6 receptor (IL-6R), playing a crucial role in the modulation of inflammatory responses. This antibody is specifically designed for the study of inflammatory diseases, including rheumatoid arthritis, where IL-6R-mediated signaling is implicated in disease pathology and progression. Levilimab provides a valuable tool for researchers investigating the therapeutic potential of IL-6R inhibition in inflammation and autoimmune disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
